NFE2L2 and acute myeloid leukemia: To furthermore explore the association of Nrf2 with the crucial pathway mediating drug resistance in AML, we first divided AML samples into Nrf2 high expression (Nrf2-high) group and low expression (Nrf2-low) group based on the median value of Nrf2 expression and compared BER signaling pathway–related factors.